Delivery Order SPE2DR25D2104-SPE2DR26F3RLH
- Not listed
- The Defense Logistics Agency awarded a $1,293.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $18,986.97 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% Eye Emulsion (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical distributors....
- The Defense Logistics Agency awarded a $2,570.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. The contract, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Restasis 0.05% eye emulsion in 60-count units. This non-competitive delivery order, valued at $11,404.78, was executed on October 20, 2025, with an ultimate completion date of October 21, 2025. The contract employs firm fixed pricing and represents a direct fulfillment of pharmaceutical needs within the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $21,962.40 to supply Restasis 0.05% Eye Emulsion in 60-unit quantities. This contract, which was competitively awarded without set-aside restrictions, has a firm fixed price structure with an ultimate completion date of November 19, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a $10,783.83 firm fixed-price delivery order for Restasis 0.05% Eye Emulsion (60 units), with an ultimate completion date of December 5, 2025. This is a competitively awarded, non-set-aside contract with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $3,916.15 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% Eye Emulsion (60 units) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Restasis 0.05% Eye Emulsion in 60-count units, with a contract ceiling value of $22,836.31. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award selection. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Restasis 0.05% Eye Emulsion (30-count packaging) with a ceiling value of $2,782.42. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 8, 2025. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,541.08 for Restasis 0.05% Eye Emulsion (30-count units) on May 6, 2025, with an ultimate completion date of May 7, 2025. This firm fixed-price delivery order represents a non-competitive procurement under a larger indefinite delivery contract vehicle. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3RLHDelivery Order
The Defense Logistics Agency awarded a $2,178.96 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30 count) with a firm fixed price and an ultimate completion date of December 15, 2025. This is a non-set-aside competitive award, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor with extensive experience fulfilling Department of Defense healthcare requirements. The company's contract portfolio with the DLA Medical Supply Chain demonstrates its capability to deliver a comprehensive range of pharmaceutical products including brand-name and generic medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic domains. This award reflects the contractor's ongoing role as a preferred supplier within the federal healthcare procurement system, supporting military and veteran healthcare operations through competitively awarded delivery orders with consistent firm fixed pricing arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/13/25 |